259 related articles for article (PubMed ID: 26900145)
1. Preference weights for the spectrum of alcohol use in the U.S. Population.
Chavez LJ; Bradley K; Tefft N; Liu CF; Hebert P; Devine B
Drug Alcohol Depend; 2016 Apr; 161():206-13. PubMed ID: 26900145
[TBL] [Abstract][Full Text] [Related]
2. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W
Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061
[TBL] [Abstract][Full Text] [Related]
3. An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population.
Petrou S; Hockley C
Health Econ; 2005 Nov; 14(11):1169-89. PubMed ID: 15942981
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the EQ-5D 3L and the SF-6D (SF-36) contemporaneous utility scores in patients with chronic kidney disease in Sri Lanka: a cross-sectional survey.
Kularatna S; Senanayake S; Gunawardena N; Graves N
BMJ Open; 2019 Feb; 9(2):e024854. PubMed ID: 30772857
[TBL] [Abstract][Full Text] [Related]
5. Relative disutilities of 47 risk factors and conditions assessed with seven preference-based health status measures in a national U.S. sample: toward consistency in cost-effectiveness analyses.
Franks P; Hanmer J; Fryback DG
Med Care; 2006 May; 44(5):478-85. PubMed ID: 16641667
[TBL] [Abstract][Full Text] [Related]
6. Alcohol drinking patterns and health-related quality of life reported in the Spanish adult population.
Valencia-Martín JL; Galán I; Guallar-Castillón P; Rodríguez-Artalejo F
Prev Med; 2013 Nov; 57(5):703-7. PubMed ID: 24051265
[TBL] [Abstract][Full Text] [Related]
7. Health Condition Impacts in a Nationally Representative Cross-Sectional Survey Vary Substantially by Preference-Based Health Index.
Hanmer J; Cherepanov D; Palta M; Kaplan RM; Feeny D; Fryback DG
Med Decis Making; 2016 Feb; 36(2):264-74. PubMed ID: 26314728
[TBL] [Abstract][Full Text] [Related]
8. Comparing the Performance of 2 Health Utility Measures in the Medicare Health Outcome Survey (HOS).
Jia H; Lubetkin EI; DeMichele K; Stark DS; Zack MM; Thompson WW
Med Decis Making; 2018 Nov; 38(8):983-993. PubMed ID: 30403580
[TBL] [Abstract][Full Text] [Related]
9. Comparison of FACT- and EQ-5D-based utility scores in cancer.
Pickard AS; Ray S; Ganguli A; Cella D
Value Health; 2012; 15(2):305-11. PubMed ID: 22433762
[TBL] [Abstract][Full Text] [Related]
10. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.
Hawton A; Green C; Telford C; Zajicek J; Wright D
Value Health; 2012 Dec; 15(8):1084-91. PubMed ID: 23244811
[TBL] [Abstract][Full Text] [Related]
11. A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia.
McCrone P; Patel A; Knapp M; Schene A; Koeter M; Amaddeo F; Ruggeri M; Giessler A; Puschner B; Thornicroft G
J Ment Health Policy Econ; 2009 Mar; 12(1):27-31. PubMed ID: 19346564
[TBL] [Abstract][Full Text] [Related]
12. Mapping the cancer-specific EORTC QLQ-C30 to the preference-based EQ-5D, SF-6D, and 15D instruments.
Kontodimopoulos N; Aletras VH; Paliouras D; Niakas D
Value Health; 2009; 12(8):1151-7. PubMed ID: 19558372
[TBL] [Abstract][Full Text] [Related]
13. Comparison of contemporaneous EQ-5D and SF-6D responses using scoring algorithms derived from similar valuation exercises.
Whitehurst DG; Norman R; Brazier JE; Viney R
Value Health; 2014 Jul; 17(5):570-7. PubMed ID: 25128050
[TBL] [Abstract][Full Text] [Related]
14. Predicting the EuroQol Group's EQ-5D index from CDC's "Healthy Days" in a US sample.
Jia H; Zack MM; Moriarty DG; Fryback DG
Med Decis Making; 2011; 31(1):174-85. PubMed ID: 20375418
[TBL] [Abstract][Full Text] [Related]
15. Quality-adjusted life expectancies in patients with rheumatoid arthritis--comparison of index scores from EQ-5D, 15D, and SF-6D.
Sørensen J; Linde L; Ostergaard M; Hetland ML
Value Health; 2012; 15(2):334-9. PubMed ID: 22433765
[TBL] [Abstract][Full Text] [Related]
16. Health utility scores in Alzheimer's disease: differences based on calculation with American and Canadian preference weights.
Oremus M; Tarride JE; Clayton N; ; Raina P
Value Health; 2014; 17(1):77-83. PubMed ID: 24438720
[TBL] [Abstract][Full Text] [Related]
17. Validation and comparison of EuroQol and short form 6D in chronic prostatitis patients.
Zhao FL; Yue M; Yang H; Wang T; Wu JH; Li SC
Value Health; 2010 Aug; 13(5):649-56. PubMed ID: 20412540
[TBL] [Abstract][Full Text] [Related]
18. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis.
Marra CA; Woolcott JC; Kopec JA; Shojania K; Offer R; Brazier JE; Esdaile JM; Anis AH
Soc Sci Med; 2005 Apr; 60(7):1571-82. PubMed ID: 15652688
[TBL] [Abstract][Full Text] [Related]
19. Interchangeability of the EQ-5D and the SF-6D in long-lasting low back pain.
Søgaard R; Christensen FB; Videbaek TS; Bünger C; Christiansen T
Value Health; 2009 Jun; 12(4):606-12. PubMed ID: 19900258
[TBL] [Abstract][Full Text] [Related]
20. Responsiveness of EQ-5D utility indices in alcohol-dependent patients.
Günther OH; Roick C; Angermeyer MC; König HH
Drug Alcohol Depend; 2008 Jan; 92(1-3):291-5. PubMed ID: 17888587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
